Position in BMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$489,424
-$52,605 QoQ
Shares Held
8,494
-5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,553
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. BMY ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
8,494 | $489,424 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,424 | 8,494 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $542,029 | 8,937 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $482,061 | 8,937 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $552,384 | 12,248 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $566,867 | 12,246 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $834,648 | 13,685 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $829,848 | 14,672 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $759,025 | 14,670 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $682,296 | 16,429 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $934,274 | 17,228 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $901,824 | 17,576 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $828,637 | 14,277 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,010,793 | 15,806 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,218,677 | 17,583 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,276,968 | 17,748 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,170,994 | 16,472 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,267,112 | 16,456 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,232,746 | 16,880 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,071,110 | 17,179 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,004,588 | 16,978 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,177,167 | 17,617 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,192,588 | 18,891 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,269,940 | 20,473 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,303,590 | 21,622 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,244,854 | 21,171 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,189,826 | 21,346 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||